RU93051543A - Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей - Google Patents

Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей

Info

Publication number
RU93051543A
RU93051543A RU93051543/14A RU93051543A RU93051543A RU 93051543 A RU93051543 A RU 93051543A RU 93051543/14 A RU93051543/14 A RU 93051543/14A RU 93051543 A RU93051543 A RU 93051543A RU 93051543 A RU93051543 A RU 93051543A
Authority
RU
Russia
Prior art keywords
producing
pharmaceutical composition
malignant tumors
acridine derivatives
treating malignant
Prior art date
Application number
RU93051543/14A
Other languages
English (en)
Other versions
RU2119482C1 (ru
Inventor
Бернар Дюмэтр Андре
Додик Нерина
Original Assignee
Лаборатуар Глаксо С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB919100628A external-priority patent/GB9100628D0/en
Priority claimed from GB919100637A external-priority patent/GB9100637D0/en
Priority claimed from GB919115956A external-priority patent/GB9115956D0/en
Priority claimed from GB919115981A external-priority patent/GB9115981D0/en
Application filed by Лаборатуар Глаксо С.А. filed Critical Лаборатуар Глаксо С.А.
Publication of RU93051543A publication Critical patent/RU93051543A/ru
Application granted granted Critical
Publication of RU2119482C1 publication Critical patent/RU2119482C1/ru

Links

Claims (1)

  1. Новые соединения могут повышать чувствительность мультилекарственно-резистентных раковых клеток к химиотерапевтическим агентам и могут быть сформулированы для использования в терапии, особенно для улучшения или повышения эффективности противоопухолевого лекарства.
RU93051543A 1991-01-11 1992-01-07 Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей RU2119482C1 (ru)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB9100637.9 1991-01-11
GB919100628A GB9100628D0 (en) 1991-01-11 1991-01-11 Chemical compounds
GB9100628.8 1991-01-11
GB919100637A GB9100637D0 (en) 1991-01-11 1991-01-11 Chemical compounds
GB9115981.4 1991-07-24
GB919115956A GB9115956D0 (en) 1991-07-24 1991-07-24 Chemical compounds
GB919115981A GB9115981D0 (en) 1991-07-24 1991-07-24 Chemical compounds
GB9115956.6 1991-07-24

Publications (2)

Publication Number Publication Date
RU93051543A true RU93051543A (ru) 1996-11-10
RU2119482C1 RU2119482C1 (ru) 1998-09-27

Family

ID=27450605

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93051543A RU2119482C1 (ru) 1991-01-11 1992-01-07 Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей

Country Status (25)

Country Link
US (1) US5604237A (ru)
EP (2) EP0569380B1 (ru)
JP (1) JP2783680B2 (ru)
KR (1) KR100220538B1 (ru)
AT (1) ATE153660T1 (ru)
AU (1) AU652996B2 (ru)
CA (1) CA2100258C (ru)
CZ (1) CZ283038B6 (ru)
DE (1) DE69220037T2 (ru)
DK (1) DK0569380T3 (ru)
ES (1) ES2104887T3 (ru)
FI (1) FI103888B (ru)
GE (1) GEP20002210B (ru)
GR (1) GR3024525T3 (ru)
HU (2) HUT68856A (ru)
IE (1) IE920083A1 (ru)
IL (1) IL100631A (ru)
MX (1) MX9200109A (ru)
NO (1) NO300267B1 (ru)
NZ (1) NZ241278A (ru)
PL (1) PL168202B1 (ru)
RU (1) RU2119482C1 (ru)
SG (1) SG45403A1 (ru)
SK (1) SK280864B6 (ru)
WO (1) WO1992012132A1 (ru)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100258C (en) * 1991-01-11 1999-12-14 Bernard Andre Dumaitre Acridine derivatives
TR28930A (tr) * 1992-05-07 1997-07-21 Zeneca Ltd Alkil sübstitüentli nitrotoluen türevleri
GB9209872D0 (en) * 1992-05-07 1992-06-24 Ici Plc Alkyl substituted nitrotoluene derivatives
JP2718830B2 (ja) * 1992-07-10 1998-02-25 ラボラトワール、グラクソ、ソシエテ、アノニム アニリド誘導体
RU2036198C1 (ru) * 1993-04-01 1995-05-27 Товарищество с ограниченной ответственностью "Полисан" N-МЕТИЛ-N-( α,D -ГЛЮКОПИРАНОЗИЛ) АММОНИЯ-2-(АКРИДОН-9-ОН-10-ИЛ)АЦЕТАТ(ЦИКЛОФЕРОН), ОБЛАДАЮЩИЙ ИНТЕРФЕРОНОГЕННОЙ, ПРОТИВОВИРУСНОЙ, В ТОМ ЧИСЛЕ АНТИВИЧ, АНТИПАРАЗИТАРНОЙ, АНТИПРОМОТОРНОЙ И РАДИОПРОТЕКТИВНОЙ АКТИВНОСТЬЮ
US5387685A (en) * 1993-07-16 1995-02-07 American Cyanamid Co MDR reversal agents
DE4422517A1 (de) * 1994-06-28 1996-01-04 Dresden Arzneimittel Neue (2-(3,4-Dimethoxy-phenyl)-ethyl)-(2-phenoxy-ethyl)-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ATE248802T1 (de) * 1994-08-04 2003-09-15 C & C Res Labs Neues amin-derivat, verfahren zur herstellung und dessen verwendung als anti-arrhythmisches mittel
KR970705997A (ko) * 1994-10-05 1997-11-03 그래함 브레레톤 N-{4-[2-(1, 2, 3, 4-테트라히드로-6, 7-디메톡시-2-이소퀴놀리닐)-에틸]-페닐}-9, 10-디히드로-5-메톡시-9-옥소-4-아크리딘 카르복사미드 화합물(gf120918a)을 포함하는 비경구 제약 조성물(parenteral pharmaceutical compositions containing gf120918a)
FR2726267B1 (fr) * 1994-10-26 1998-01-02 Smithkline Beecham Lab Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer
WO1998053811A1 (en) * 1997-05-27 1998-12-03 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
US6245805B1 (en) 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
US6395770B1 (en) 1995-10-26 2002-05-28 Baker Norton Pharmaceuticals, Inc. Method and compositions for administering taxanes orally to human patients
AU1597197A (en) * 1996-02-01 1997-08-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Thienoquinolines
US6713517B1 (en) 1996-03-08 2004-03-30 Oxigene, Inc. Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such use
RU2118532C1 (ru) * 1996-04-10 1998-09-10 Олег Викторович Травкин Противоинфекционное, противовоспалительное и противоопухолевое лекарственное средство
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9710612D0 (en) * 1997-05-23 1997-07-16 Glaxo Group Ltd Synthesis of acridine derivatives
GB9718903D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
GB9812189D0 (en) * 1998-06-05 1998-08-05 Glaxo Group Ltd Methods and compositions for increasing penetration of HIV protease inhibitors
WO2000000472A1 (en) * 1998-06-30 2000-01-06 Du Pont Pharmaceuticals Company 5-ht7 receptor antagonists
CZ20011270A3 (cs) 1998-10-08 2001-09-12 Smithkline Beecham Plc Tetrahydrobenzazepinové deriváty vhodné jako modulátory dopaminových receptorů D3
EP1189637B1 (en) 1999-05-17 2006-08-23 Cancer Research Ventures Limited Compositions for improving bioavailability of orally administered drugs
EP1229934B1 (en) 1999-10-01 2014-03-05 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6521635B1 (en) 2000-01-20 2003-02-18 The United States Of America As Represented By The Department Of Health And Human Services Inhibition of MXR transport by acridine derivatives
WO2001060351A2 (en) 2000-02-18 2001-08-23 New York Medical College Nitroacridine/tumor inhibitor compositions
HU227811B1 (en) * 2000-03-14 2012-03-28 Actelion Pharmaceuticals Ltd 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes
WO2001085693A1 (fr) 2000-05-11 2001-11-15 Banyu Pharmaceutical Co., Ltd. Dérivés n-acyltétrahydroisoquinoline
CN1469735A (zh) * 2000-10-16 2004-01-21 ����˹��ҩ�﹫˾ 米托蒽醌的脂质体制剂
US7524861B2 (en) * 2002-05-14 2009-04-28 David Frank Hayman Process for the preparation of a hydrate of an anthranilic acid derivative
WO2004039795A2 (en) * 2002-10-29 2004-05-13 Fujisawa Pharmaceutical Co., Ltd. Amide compounds for the treatment of hyperlipidemia
SI1751111T1 (sl) 2004-03-01 2015-04-30 Actelion Pharmaceuticals Ltd. Substituirani 1,2,3,4-tetrahidroizokinolinski derivati
RU2346692C2 (ru) * 2007-03-29 2009-02-20 Ефаг АО Применение 9-оксоакридин-10-уксусной кислоты, ее солей и сложных эфиров в комбинированной терапии рака яичников, способ лечения и наборы
SE531698C2 (sv) * 2007-07-12 2009-07-07 Respiratorius Ab Nya bronkdilaterande a,b-omättade amider
WO2015142670A1 (en) * 2014-03-15 2015-09-24 Medisyn Technologies, Inc. Anti-diabetic compounds, pharmaceutical compositions containing them, and method to treat diabetes
CN104434808A (zh) 2014-07-03 2015-03-25 石药集团中奇制药技术（石家庄）有限公司 一种治疗性纳米粒子及其制备方法
BR112020018669A2 (pt) * 2018-03-21 2020-12-29 Izumi Technology, Llc Análogos deuterados de elacridar
CN115385847B (zh) * 2021-06-15 2023-09-29 山东第一医科大学(山东省医学科学院) 多取代二芳基类化合物及其制备方法和应用
CN117414367A (zh) * 2022-08-09 2024-01-19 北京清华长庚医院 一种逆转仑伐替尼耐药的药物组合物及其用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4250182A (en) * 1972-02-24 1981-02-10 Burroughs Wellcome Co. Pharmaceutical composition containing acridone compounds and method of using same
US4021551A (en) * 1972-06-07 1977-05-03 Boehringer Ingelheim Gmbh 3,6-Bis-(heterocyclic aminoacyl-amino)-acridines and salts thereof
US4127573A (en) * 1972-09-06 1978-11-28 Burroughs Wellcome Co. Ditetrazole substituted acridone compounds
EP0048898B1 (en) * 1980-09-30 1985-04-17 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
NZ198115A (en) * 1981-08-21 1985-05-31 New Zealand Dev Finance 9-anilinoacridines;pharmaceutical compositions
NZ201084A (en) * 1982-06-25 1985-10-11 New Zealand Dev Finance 4-carboxamidoacridine derivatives and pharmaceutical compositions containing such
IN164921B (ru) * 1986-07-22 1989-07-08 Hoechst India
US5104858A (en) * 1988-09-29 1992-04-14 Yale University Sensitizing multidrug resistant cells to antitumor agents
CA1340821C (en) * 1988-10-06 1999-11-16 Nobuyuki Fukazawa Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components
PT94402A (pt) * 1989-06-19 1991-03-20 Wellcome Found Processo para a preparacao de compostos azotados que contem sistemas de aneis ciclicos aromaticos e de composicoes farmaceuticas que os contem
CA2100258C (en) * 1991-01-11 1999-12-14 Bernard Andre Dumaitre Acridine derivatives
US5296602A (en) * 1991-03-18 1994-03-22 Sloan-Kettering Institute For Cancer Research Multisubstituted 1-hydroxy-9-acridones with anticancer activity
US5240936A (en) * 1992-05-14 1993-08-31 Texas A&M University System Treating or preventing ocular inflammation or systemic imflammatory disease

Similar Documents

Publication Publication Date Title
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
DE9290018U1 (de) 2,4-Diaminochinazolin-Derivate zur Verbesserung der Antitumor-Aktivität
FI932032A (fi) Kinazolinderivat foer oekande av antitumoeraktivitet
DE3689363T2 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
IS4073A (is) Nýtt fjölvirknislyf gegn aukningu mótstöðu
ES8706965A1 (es) Un metodo de formacion de un conjugado de proteina y quelato metalico
TR200102603T2 (tr) Antitümör aktiviteye sahip olan kamptotesin türevleri
UA49787C2 (ru) Способ увеличения цитотоксичности химиотерапевтического агента и способ увеличения цитотоксичности днк-алкилирующего химиотерапевтического агента
EP0172721A3 (en) Use of phlorizin or its derivatives in the treatment of cancer
IT1238231B (it) Impiego di immunomodulanti come agenti sinergici di chemioterapici nella terapia dei tumori
IL62615A0 (en) Organic complex of platinum,its preparation and its use for treating malignant tumours
CA2202531A1 (en) Lyophilizate of lipid complex of water insoluble camptothecins
RU93004860A (ru) Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
AU1206292A (en) Therapeutic agents for the treatment of multidrug resistance to cancers
ZA845670B (en) Coumarin derivatives,pharmaceutical compositions containing the same,and the use thereof in the treatment of cancer
NO880908L (no) Kombinasjonsterapi med bruk av antitumor immunotoksiner med tumornekrosefaktor.
AU8355598A (en) The use of 1,3,4,6-tetrahydroxy-helianthrone and its derivatives in phot odynamictherapy and certain such novel derivatives
DE69814691T2 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ES8103090A1 (es) Un procedimiento para la preparacion de espiro-quinolilludantoinas, utiles como inhibidores de la aldosa-reductasa para el tratamiento de las complicaciones cronicas de la diabetes
EP0345356A4 (en) Platinum complex and therapeutic agent for malignant tumor
IT1188904B (it) Composti farmaceutici dotati di attivita' antidepressiva e procedimento per la loro preparazione
RU93034452A (ru) Производные хиназолинов для усиления противоопухолевой активности, способ их получения, способ лечения и фармацевтическая композиция
RU93052408A (ru) Ациламино-алкилиден-гидрокси-бис-фосфоновые кислоты, способ их получения, фармацевтическая композиция
CA2045593A1 (en) Use of 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans